CN1278528A - Process for preparation of 5,6-dihydroxyl-2-amino-1,2,3,4-tetrahydronaphthalene derivatives - Google Patents
Process for preparation of 5,6-dihydroxyl-2-amino-1,2,3,4-tetrahydronaphthalene derivatives Download PDFInfo
- Publication number
- CN1278528A CN1278528A CN00103698A CN00103698A CN1278528A CN 1278528 A CN1278528 A CN 1278528A CN 00103698 A CN00103698 A CN 00103698A CN 00103698 A CN00103698 A CN 00103698A CN 1278528 A CN1278528 A CN 1278528A
- Authority
- CN
- China
- Prior art keywords
- amino
- acid
- tetralin
- dihydroxy
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
本发明涉及一种制备结构式(I)的5,6-二羟基-2-氨基-1,2,3,4-四氢化萘(或氨基-1,2,3,4-四氢化萘)(5,式中R1,R2和R3,可以相同或不同,是氢或者直链或支链低级烷基。The present invention relates to a kind of preparation structure formula (I) 5,6-dihydroxy-2-amino-1,2,3,4-tetralin (or amino-1,2,3,4-tetrahydronaphthalene) ( 5, In the formula, R 1 , R 2 and R 3 , which may be the same or different, are hydrogen or straight or branched lower alkyl.
氨基-1,2,3,4-四氢化萘是具有显著拟交感神经活性的化合物。Amino-1,2,3,4-tetralin is a compound with pronounced sympathomimetic activity.
由于其性质,这些化合物可以作为药物对支气气管、心血管、肾脏和中枢神经系统为活性而应用于不同的治疗领域。Due to their properties, these compounds can be used in different therapeutic fields as drugs active on the bronchial, cardiovascular, renal and central nervous systems.
很多用于制备5,6-ADTN的方法公开在自六十年代末以来的文献和专利中。Many methods for the preparation of 5,6-ADTN are disclosed in literature and patents since the late sixties.
某些合成需要制备5,6-二甲氧-1-四氢萘酮,然后再用各种方法将其转变成5,6-ADTN:通过5,6-二甲氧基-1-四氢萘酮O-甲苯磺酰基肟的Neber重排(W.K.Sprenger等人,J.Med.Chem.,12,487,1969,由J.C.Kim等人进行了改进,J.Kor.Chem.Soc.,21(3),187,1977),通过α-溴化处理和随后取代溴(J.C.Kim等人,J.Kor.Chem.Soc.,20,91,1976;Y.Oka等人,Chem.Pharm.Bull.,25(4),632,1977)。通过α-亚硝化和随后还原(Y.Oka等人,Chem.Pharm.Bull.,25(4),632,1977)。Certain syntheses require the preparation of 5,6-dimethoxy-1-tetralone, which is then converted to 5,6-ADTN by various methods: via 5,6-dimethoxy-1-tetrahydro Neber rearrangement of naphthalenone O-tosyl oxime (W.K. Sprenger et al., J.Med.Chem., 12, 487, 1969, improved by J.C.Kim et al., J.Kor.Chem.Soc., 21 (3), 187, 1977), by α-bromination treatment and subsequent substitution of bromine (J.C.Kim et al., J.Kor.Chem.Soc., 20, 91, 1976; Y.Oka et al., Chem.Pharm. Bull., 25(4), 632, 1977). By α-nitrosation and subsequent reduction (Y. Oka et al., Chem. Pharm. Bull., 25(4), 632, 1977).
某些合成需要制备5,6-二甲氧基-2-四氢萘酮,然后通过下列方法转变成相应的2-氨基衍生物:通过还原性胺化作用(J.D.McDermed等人,J.Med.Chem.,18(4),362,1975;J.G.Cannon等人,J.Med.Chem.,20(9),1111,1977;美国专利US 646300(IowaUniv.)),或者通过将其转变成相应的邻甲基肟然后再还原(J.G.Cannon等人,J.Med.Chem.,17(5),565,1974)。Certain syntheses require the preparation of 5,6-dimethoxy-2-tetralone, which is then converted to the corresponding 2-amino derivative by reductive amination (J.D.McDermed et al., J.Med .Chem., 18(4), 362,1975; J.G.Cannon et al., J.Med.Chem., 20(9), 1111,1977; U.S. Patent US 646300 (IowaUniv.)), or by converting it into The corresponding o-methyloxime is then reduced again (J.G.Cannon et al., J.Med.Chem., 17(5), 565, 1974).
某些合成是基于制备5-羟基-6-甲氧基-1,2,3,4,-四氢-2-萘甲酸然后用库尔提斯重排转变成5,6-ADTN(K.Mitsuhashi等人,Chem.Pharm.Bull.,20(6),1321,1972)。Certain syntheses are based on the preparation of 5-hydroxy-6-methoxy-1,2,3,4,-tetrahydro-2-naphthoic acid followed by Curtis rearrangement into 5,6-ADTN (K. Mitsuhashi et al., Chem. Pharm. Bull., 20(6), 1321, 1972).
唯一的对映选择(enantiospecific)合成5,6-ADTN是基于使用2,2-二甲基-3-甲氧基羰基-噁唑烷-4-醛(A.D.Baxter等人,Tetrahedron Letters,33(17),2331,1992)。The only enantiospecific synthesis of 5,6-ADTN is based on the use of 2,2-dimethyl-3-methoxycarbonyl-oxazolidin-4-aldehyde (A.D. Baxter et al., Tetrahedron Letters, 33( 17), 2331, 1992).
所有这些方法都受到工业应用的严格限制。All these methods are severely limited for industrial application.
目前,工业上可接受的制备2-氨基-5,6-二甲氧基-1,2,3,4-四氢化萘的方法已在EP-A-0534536中要求保护(1991年9月17日申请,申请人为Zambon)。At present, the method for preparing 2-amino-5,6-dimethoxy-1,2,3,4-tetralin which is industrially acceptable has been claimed in EP-A-0534536 (September 17, 1991 date of application, the applicant is Zambon).
根据后一个参考文献,通过用关键的中间体即相应的1-四氢萘酮(在上面引用的文献中已经充分说明)而得到5,6-二甲氧基-2-氨基-1,2,3,4-四氢化萘。开始由2,3-二甲氧基苯甲醛与丙酮酸缩合得到四氢萘酮(步骤A),将酮基转变成氨基并还原不饱和的氨基酸(步骤B),之后进行分子内环化则得到所需的5,6-二甲氧基-2-氨基(保护的)-1-四氢萘酮。According to the latter reference, 5,6-dimethoxy-2-amino-1,2 , 3,4-Tetralin. Start by condensing 2,3-dimethoxybenzaldehyde with pyruvic acid to obtain tetralone (step A), convert the ketone group into amino and reduce unsaturated amino acids (step B), and then carry out intramolecular cyclization The desired 5,6-dimethoxy-2-amino(protected)-1-tetralone is obtained.
Hudson等人(J.Chem.Soc.,715-722(1941))和Pavel等人(ActaUniv.Palacki Olomuc.Fac.Rerum.Natur.,401-404(1971))早已经公开过该缩合反应(步骤A)。Hudson et al. (J.Chem.Soc., 715-722 (1941)) and Pavel et al. (ActaUniv.Palacki Olomuc.Fac.Rerum.Natur., 401-404 (1971)) have already disclosed this condensation reaction ( Step A).
关于这点,EP0534536强调指出,在存在无机碱时,例如氢氧化钠(Hudson)或碳酸钾(Pavel),这种反应的产率非常低(分别为40%和6%),因而它不具有工业应用意义。In this regard, EP0534536 emphasizes that in the presence of inorganic bases, such as sodium hydroxide (Hudson) or potassium carbonate (Pavel), the yields of this reaction are very low (40% and 6%, respectively), so that it does not have significance for industrial applications.
在上述的EP0534536中,通过在存在有机碱例如三乙胺、哌啶、哌嗪和吗啉下进行该缩合反应解决了产率低的问题。可以以高达约80%的产率得到该缩合产物。这里所述的缩合反应需要特别的反应条件,例如无水有机溶剂(指出了二甲基甲酰胺)、惰性气氛、在加入试剂期间要低温。产物的回收需要萃取步骤以去除有机溶剂。In the aforementioned EP0534536, the problem of low yield was solved by carrying out the condensation reaction in the presence of an organic base such as triethylamine, piperidine, piperazine and morpholine. The condensation product can be obtained in yields of up to about 80%. The condensation reactions described here require special reaction conditions such as anhydrous organic solvents (dimethylformamide is indicated), an inert atmosphere, and low temperatures during addition of reagents. Recovery of the product requires an extraction step to remove the organic solvent.
从工业应用的观点来说,上述的缩合反应对于试剂、无水溶剂和设备的要求来说都具有附加的成本支出。From the point of view of industrial application, the above-mentioned condensation reactions have additional cost expenditures for reagents, anhydrous solvents and equipment requirements.
现在已经发现,当在水/醇溶剂中存在无机碱时进行2,3-二烷氧基苯甲醛和丙酮酸的缩合反应可以以高产率得到4-(2,3-二烷氧苯基)-2-酮基丁烯酸。该反应在室温下进行。It has now been found that the condensation of 2,3-dialkoxybenzaldehyde and pyruvic acid in the presence of an inorganic base in an aqueous/alcoholic solvent gives 4-(2,3-dialkoxyphenyl) in high yield -2-ketobutenoic acid. The reaction is carried out at room temperature.
本发明提供了一种制备式I的5,6-二羟基-2-氨基-1,2,3,4-四氢化萘衍生物及其酸加成盐的方法: The present invention provides a method for preparing 5,6-dihydroxy-2-amino-1,2,3,4-tetralin derivatives of formula I and their acid addition salts:
其中R1,R2和R3可相同或不同,是氢或C1-C4烷基,该方法包括下列步骤:Wherein R 1 , R 2 and R 3 can be the same or different, and are hydrogen or C 1 -C 4 alkyl, the method comprises the following steps:
(a)将2-酮基-4-(2,3-二烷氧基苯基)丁烯酸的2-位的酮基转变或替代成氨基,烷氨基或烷氧基羰基氨基,得到式II的化合物 (a) the keto group at the 2-position of 2-keto-4-(2,3-dialkoxyphenyl)butenoic acid is converted or replaced into amino, alkylamino or alkoxycarbonylamino to obtain the formula Compound of II
其中R′1是氢,烷基或烷氧基羰基,R2和R3是氢或烷基;Wherein R'1 is hydrogen, alkyl or alkoxycarbonyl, R2 and R3 are hydrogen or alkyl;
b)分子内环化得到式III的5,6-二羟基或5,6-二烷氧基-2-氨基或2-烷基氨基或2-烷氧羰基氨基-1-四氢萘酮 b) intramolecular cyclization to obtain 5,6-dihydroxy or 5,6-dialkoxy-2-amino or 2-alkylamino or 2-alkoxycarbonylamino-1-tetralone of formula III
其中R1′是氢,烷基或烷氧羰基和R2和R3是氢或烷基;wherein R1 ' is hydrogen, alkyl or alkoxycarbonyl and R2 and R3 are hydrogen or alkyl;
c)还原该酮基得到式IV的5,6-二羟基/5,6-二烷氧基-2-氨基/2-烷基氨基/2-烷氧基羰基氨基-1,2,3,4-四氢化萘其中R′1是氢,烷基或烷氧羰基,R2和R3是氢或烷基。本发明的一个方面提供一种用于制备结构式(I)化合物的方法:该方法包括:c) reduction of the keto group to obtain 5,6-dihydroxyl/5,6-dialkoxy-2-amino/2-alkylamino/2-alkoxycarbonylamino-1,2,3 of formula IV, 4-tetralin wherein R'1 is hydrogen, alkyl or alkoxycarbonyl, and R2 and R3 are hydrogen or alkyl. One aspect of the present invention provides a method for the preparation of compounds of structural formula (I): The method includes:
(a)在水/醇体系中并且在有无机碱条件下将2,3-二烷氧基苯甲醛与丙酮酸缩合,得到2-酮基-4-(2,3-二烷氧基苯基)-丁烯酸;(a) Condensation of 2,3-dialkoxybenzaldehyde with pyruvic acid in water/alcohol system and presence of inorganic base to give 2-keto-4-(2,3-dialkoxybenzene base)-butenoic acid;
(b)将所述酸的酮基转变成氨基或烷基氨基,同时还原双键,则分别得到2-氨基或2-烷基氨基-4-(2,3-二烷氧基苯基)丁酸;(b) the keto group of the acid is converted into amino or alkylamino, and the double bond is reduced simultaneously to obtain 2-amino or 2-alkylamino-4-(2,3-dialkoxyphenyl) respectively butyric acid;
(c)将2-氨基或2-烷基氨基-4-(2,3-二烷氧基苯基)丁酸转变成4-(2-(2,3-二烷氧基苯基)乙基)-N-烷基-2,5-噁唑烷-二酮;(c) converting 2-amino or 2-alkylamino-4-(2,3-dialkoxyphenyl)butanoic acid into 4-(2-(2,3-dialkoxyphenyl)ethyl base)-N-alkyl-2,5-oxazolidine-dione;
(d)在路易斯酸存在下通过弗瑞德-克来福分子内酰化作用将N-羧基酐环化,则直接得到未保护的5,6-二烷氧基-2-烷基氨基-1-四氢萘酮;(d) Cyclization of N-carboxyl anhydride by Friedel-Craft intramolecular acylation in the presence of a Lewis acid, the unprotected 5,6-dialkoxy-2-alkylamino- 1-tetralone;
(e)将该酮催化还原则得到5,6-二烷氧基-2-烷基氨基-1,2,3,4-四氢化萘,和(如果需要)(e) catalytic reduction of the ketone to 5,6-dialkoxy-2-alkylamino-1,2,3,4-tetralin, and (if desired)
(f)将该5,6-二烷氧基-2-烷基氨基-1,2,3,4-四氢化萘进行0-脱烷基化则得到5,6-二羟基-2-烷基氨基-1,2,3,4-四氢化萘。(f) O-dealkylation of the 5,6-dialkoxy-2-alkylamino-1,2,3,4-tetralin gives 5,6-dihydroxy-2-alkane Amino-1,2,3,4-tetrahydronaphthalene.
在合适条件下通过使用卤代含氢的酸(halo hydric acid)或路易斯酸可以减少该方法的步骤,从N-羧基酐直接得到未保护的5,6-二羟基-2-烷基氨基-1-四氢萘酮。The steps of the method can be reduced by using halo hydric acid or Lewis acid under suitable conditions, and the unprotected 5,6-dihydroxy-2-alkylamino- 1-tetralone.
另一方面,本发明的方法包括上述的步骤(a)和(b),然后:On the other hand, the method of the present invention comprises above-mentioned steps (a) and (b), then:
(c)将2-烷基氨基-4-(2,3-二烷氧基苯基)丁酸环化同时在氧上进行脱烷基化,则一步直接得到2-烷基氨基-5,6-二羟基-1-四氢萘酮;(c) cyclization of 2-alkylamino-4-(2,3-dialkoxyphenyl) butanoic acid and dealkylation on oxygen, then one step directly obtains 2-alkylamino-5, 6-dihydroxy-1-tetralone;
(d)将该酮催化还原则得到5,6-二羟基-2-烷基氨基-1,2,3,4-四氢化萘盐酸盐。(d) Catalytic reduction of the ketone to obtain 5,6-dihydroxy-2-alkylamino-1,2,3,4-tetralin hydrochloride.
所得最终化合物通常是盐的形式,但是本发明的方法也可以将该衍生物转变成游离碱或将其转变成另一种酸加成盐。The resulting final compound is usually in the form of a salt, but the process of the invention also makes it possible to convert the derivative into the free base or into another acid addition salt.
低级烷基的例子是直链或支链的C1-C4烷基。Examples of lower alkyl groups are linear or branched C 1 -C 4 alkyl groups.
在优选方案中,本发明提供制备其中R1是甲基而R2和R3是H的结构式(I)的化合物的方法。In a preferred embodiment, the present invention provides a process for the preparation of compounds of formula (I) wherein R 1 is methyl and R 2 and R 3 are H.
依据本发明的第一个方案,按下面反应图解I制备结构式(I)的化合物:According to the first scheme of the present invention, the compound of structural formula (I) is prepared according to the following reaction scheme I:
反应图解1 Reaction Diagram 1
下面详述每一步骤。Each step is detailed below.
第一步骤:由上述文献早已知道2,3-二甲氧苯甲醛与丙酮酸的缩合反应。 The first step : the condensation reaction of 2,3-dimethoxybenzaldehyde and pyruvic acid has long been known from the above documents.
按本发明,在含水/醇介质(优选为水/乙醇介质)中使用无机碱(优选商售氢氧化钾)进行反应,反应的产率为80%。According to the present invention, the reaction is carried out using an inorganic base (preferably commercially available potassium hydroxide) in a water/alcohol medium (preferably a water/ethanol medium), and the reaction yield is 80%.
本发明中可以使用的其它无机碱例如是氢氧化钠。Other inorganic bases that can be used in the present invention are, for example, sodium hydroxide.
第二步骤:该步骤包含通过还原性胺化作用将酮转变成烷基氨基基团。在单一步骤中用常规工序使用合适的烷基胺(例如含水甲胺)和合适的还原体系(例如在甲醇中的催化氢化(催化剂为Pd))进行该转变。该反应与双键还原一步同时进行,产率为60%。该反应使用甲胺或其它烷基胺,因而可以直接得到已用烷基在氨基上取代的2-氨基-1,2,3,4-四氢化萘衍生物,然后可被任选地取代。该介质是醇或水醇溶液,为的是满足便利和节约成本这些条件。 Second step : This step involves the conversion of the ketone to an alkylamino group by reductive amination. This transformation is carried out in a single step using a suitable alkylamine (eg aqueous methylamine) and a suitable reducing system (eg catalytic hydrogenation in methanol (catalyst Pd)) using conventional procedures. The reaction was carried out simultaneously with a double bond reduction step with a yield of 60%. The reaction uses methylamine or other alkylamines and thus directly gives 2-amino-1,2,3,4-tetralin derivatives which have been substituted at the amino group with an alkyl group, which can then be optionally substituted. The medium is an alcoholic or hydroalcoholic solution in order to meet the conditions of convenience and cost savings.
氨基酸可以盐酸盐和天然氨基酸(两性离子)的形式得到。Amino acids are available as hydrochloride salts and natural amino acids (zwitterions).
该方法也可以用氨代替烷基胺来进行,得到在胺上未取代的2-氨基-1,2,3,4-四氢化萘。The process can also be carried out with ammonia instead of alkylamines to give 2-amino-1,2,3,4-tetralins unsubstituted on the amines.
第三步骤:按常规方法(Cfr.A.R.Katritzky,C.W.ReesComprehensive Heterocyclic Chemistry,Part 4B,第231页,1984,Pergamon Press;J.P.Greenstein,M.Winitz Chemistry of the AminoAcids,Vol.2,867-868页,1961和ref.cit.),使用碳酰氯一步将氨基酸转变成相应的环状N-羧基酐。 The third step : by conventional method (Cfr.ARKatritzky, CWReesComprehensive Heterocyclic Chemistry, Part 4B, the 231st page, 1984, Pergamon Press; JP Greenstein, M.Winitz Chemistry of the AminoAcids, Vol.2, 867-868 pages, 1961 and ref .cit.), a one-step conversion of an amino acid to the corresponding cyclic N-carboxy anhydride using phosgene.
为实用目的,优选地将该反应分为两步:For practical purposes, the reaction is preferably divided into two steps:
-用合适的氯甲酸酯(如氯甲酸苄酯或氯甲酸乙酯)以定量的产率将2-烷基氨基-4-(2,3-二烷氧基苯基)丁酸中的氨基转变成氨基甲酸酯;- using a suitable chloroformate (such as benzyl chloroformate or ethyl chloroformate) to convert 2-alkylamino-4-(2,3-dialkoxyphenyl)butanoic acid in quantitative yield Amino groups are converted to carbamates;
-例如用亚硫酰氯,在不存在或存在有机溶剂下将4-(2,3-二烷氧基苯基)-2-(N-烷基-N-烷氧基羰基氨基)丁酸环化成环N-羧基酐,同时去除烷基卤化物。产率接近于定量。- 4-(2,3-dialkoxyphenyl)-2-(N-alkyl-N-alkoxycarbonylamino)butanoic acid ring, for example with thionyl chloride, in the absence or presence of an organic solvent Formation of cyclic N-carboxy anhydrides with simultaneous removal of alkyl halides. The yield is close to quantitative.
该所得产物是固态的、稳定的且易于处理而无需特别的操作处理。迄今为止,我们知道,在制备具有氨基-1,2,3,4-四氢化萘结构的化合物时使用这种特定的酐,这在文献中尚无报道。The resulting product is solid, stable and easy to handle without special handling. So far, we know that the use of this specific anhydride in the preparation of compounds having the structure of amino-1,2,3,4-tetralin has not been reported in the literature.
该方法可以在后续步骤中直接得到2-烷基氨基-5,6-二烷氧基-1-四氢萘酮,省去了氨基的保护/去保护步骤,这与EP00534536中所需的相反。This method allows direct access to 2-alkylamino-5,6-dialkoxy-1-tetralones in subsequent steps, eliminating the need for protection/deprotection of the amino group, as opposed to what is required in EP00534536 .
第四步骤:该步骤包含将4-(2-(2,3-二烷氧基苯基)乙基)-N-烷基-2,5-噁唑烷二酮进行弗瑞德-克来福分子内酰化,则得到5,6-二烷氧基-2-烷基氨基-1-四氢萘酮,该步骤按常规工序进行,例如使用三氯化铝或在无水的非质子传递溶剂(优选氯化了的)中的其它合适的路易斯酸(如BBr3、BCl3、SnCl4、TiCl4)。 Fourth step : This step involves subjecting 4-(2-(2,3-dialkoxyphenyl)ethyl)-N-alkyl-2,5-oxazolidinedione to Friedel-Craft Intramolecular acylation of Fu, then obtains 5,6-dialkoxy-2-alkylamino-1-tetralone, this step is carried out according to conventional procedures, such as using aluminum trichloride or in anhydrous aprotic Other suitable Lewis acids (eg BBr 3 , BCl 3 , SnCl 4 , TiCl 4 ) in a transfer solvent (preferably chlorinated).
第五步骤:在含水或水 醇介质中,用盐酸作酸,使用钯/炭作催化剂,将5,6-二烷氧基-2-烷基氨基-1-四氢萘酮还原成1,2,3,4-四氢化萘。产率接近于定量。 The fifth step : in a water-containing or water-alcoholic medium, use hydrochloric acid as an acid, and use palladium/carbon as a catalyst to reduce 5,6-dialkoxy-2-alkylamino-1-tetralone to 1, 2,3,4-Tetralin. The yield is close to quantitative.
第六步骤:用常规工序将5,6-二烷氧基-2-烷基氨基-1,2,3,4-四氢化萘进行可能的0-脱烷基化反应,得到5,6-二羟基-2-烷基氨基-1,2,3,4-四氢化萘,例如使用合适的浓卤代含氢酸(例如HBr水溶液)或在非质子传递非极性溶剂(如三氯化铝的无水甲苯溶液)中的合适的路易斯酸,反应的产率接近于定量。 The sixth step : 5,6-dialkoxy-2-alkylamino-1,2,3,4-tetralin is subjected to a possible O-dealkylation reaction using conventional procedures to obtain 5,6- Dihydroxy-2-alkylamino-1,2,3,4-tetrahydronaphthalene, e.g. using a suitable concentrated halogenated hydrogen-containing acid (e.g. HBr in water) or in an aprotic nonpolar solvent (e.g. trichloride Aluminum in anhydrous toluene) with the appropriate Lewis acid, the reaction yields are close to quantitative.
在本发明的第二个方案中,按下面反应图解2制备结构式(I)的化合物:反应图解2 In the second scheme of the present invention, the compound of structural formula (I) is prepared according to the following reaction scheme 2: reaction scheme 2
下面详述每个步骤:Each step is detailed below:
方法2Method 2
第一和第二步骤:按方法1的第一和第二步骤所述工序进行该第一和第二步骤。 First and second steps : carry out the first and second steps according to the procedures described in the first and second steps of method 1.
第三步骤:该步骤包含通过氨基酸的分子内酰化的环化作用,同时将儿茶酚羟基去保护。使用浓的卤代含氢酸进行该反应,例如回流下用48%氢溴酸,加压及100-140℃温度下用37%盐酸或57%氢碘酸。该反应也可以使用在非质子传递溶剂中的合适的路易斯酸(例如在二氯甲烷中的BBr3)。该步骤特别重要。 Third step : This step involves cyclization by intramolecular acylation of amino acids with simultaneous deprotection of the catechol hydroxyl groups. The reaction is carried out using a concentrated halogenated hydroacid such as 48% hydrobromic acid at reflux, 37% hydrochloric acid or 57% hydroiodic acid under pressure at a temperature of 100-140°C. The reaction may also employ a suitable Lewis acid in an aprotic solvent (eg BBr3 in dichloromethane). This step is especially important.
事实上,迄今就申请人所知,在文献中尚无记载能一步获得分子内的环化而同时使羟基去保护的方法,这种方法省去了氨基或烷基氨基的保护和去保护步骤。In fact, so far, to the applicant's knowledge, there is no description in the literature of a method capable of obtaining intramolecular cyclization in one step while deprotecting the hydroxyl group, which eliminates the protection and deprotection steps of amino or alkylamino groups .
事实上,通常所述的方法包括a)保护氨基并且按弗瑞德-克来福进行环化,或在一个步骤中使用在三氟乙酸中的三氟乙酸酐(见EP0534536)或在多个步骤中进行(见EP0534536中所引用的文献及A.D.Baxter等人Tetrahedron Letters,33(17),2331,1992);b)将该氨基去保护;c)将羟基去保护(通常用氢溴酸处理);d)将2-氨基-1,2,3,4-四氢化萘进行可能的N-烷基化。In fact, the commonly described methods consist of a) protection of the amino group and cyclization according to Friedel-Crafts, either in one step using trifluoroacetic anhydride in trifluoroacetic acid (see EP0534536) or in multiple (see references cited in EP0534536 and A.D.Baxter et al. Tetrahedron Letters, 33(17), 2331, 1992); b) deprotect the amino group; c) deprotect the hydroxyl group (usually treated with hydrobromic acid ); d) possible N-alkylation of 2-amino-1,2,3,4-tetralin.
另外,由于本发明方法具有高产率(约90%)和低的试剂成本而引起工业界的特别的兴趣。In addition, the method of the present invention is of particular interest to the industry due to its high yield (approximately 90%) and low reagent costs.
当使用不同于盐酸的酸时,只需用浓盐酸进行处理就可简单地将产物转变为氢氯化物,以得到所需的定量的成盐化作用。When an acid other than hydrochloric acid is used, the product is simply converted to the hydrochloride by treatment with concentrated hydrochloric acid to obtain the desired quantitative salification.
使用该方法也可从旋光体的氨基酸开始,以得到2-(烷基)氨基-5,6-二羟基-1-四氢萘酮的相应对称体。Using this method it is also possible to start from the amino acid of the optical form to obtain the corresponding symmetric form of 2-(alkyl)amino-5,6-dihydroxy-1-tetralone.
第四步骤:该步骤包含通过催化氢化将2-烷基氨基-5,6-二羟基-1-四氢萘酮还原得到2-烷基氨基-5,6-二羟基-1,2,3,4-四氢化萘。该反应在含水或水醇介质中进行,所用酸为盐酸,使用披钯碳作催化剂。产率接近于定量。 The fourth step : This step involves the reduction of 2-alkylamino-5,6-dihydroxy-1-tetralone by catalytic hydrogenation to obtain 2-alkylamino-5,6-dihydroxy-1,2,3 , 4-Tetralin. The reaction is carried out in water-containing or water-alcoholic medium, the acid used is hydrochloric acid, and palladium-coated carbon is used as a catalyst. The yield is close to quantitative.
依据本发明的方法,包括上述的对其进行的改性,可以直接得到在胺上用烷基取代的5,6-二羟基-2-氨基-1,2,3,4-四氢化萘,该基团然后在任选地取代。According to the method of the present invention, including the above-mentioned modification to it, the 5,6-dihydroxyl-2-amino-1,2,3,4-tetralin substituted with an alkyl group on the amine can be directly obtained, This group is then optionally substituted.
在第一个方案中,该方法提供了使用N-羧基酸酐,它有两种作用,即保护胺和活化羧基,通过随后的环化,由此可得到5,6-二甲氧基或5,6-二羟基-2-甲基氨基-1-四氢萘酮,省去了胺的去保护步骤。In the first variant, the method provides for the use of N-carboxy anhydrides, which have two functions, namely protecting the amine and activating the carboxyl group, through subsequent cyclization, whereby 5,6-dimethoxy or 5 , 6-dihydroxy-2-methylamino-1-tetralone, omitting the amine deprotection step.
本发明方法的第二个方案更具有优越性,因为只在两个步骤中就可以从2-烷基氨基-4-(2,3-二烷氧基苯基)丁酸得到5,6-二羟基-2-烷基氨基-1,2,3,4-四氢化萘,这两个步骤中的一个步骤是环化并同时使儿茶酚基团脱烷基化,而另一个步骤是还原。The second version of the method of the present invention is more advantageous, because only in two steps just can obtain 5,6- Dihydroxy-2-alkylamino-1,2,3,4-tetrahydronaphthalene, one of the two steps is cyclization and simultaneous dealkylation of the catechol group, while the other step is reduction.
迄今为止我们知道,这是得到5,6-二羟基-2-(烷基)氨基-1,2,3,4-四氢化萘,特别是5,6-二羟基-2-甲基氨基-1,2,3,4-四氢化萘的最简单且最直接的方法。As far as we know, this is to get 5,6-dihydroxy-2-(alkyl)amino-1,2,3,4-tetralin, especially 5,6-dihydroxy-2-methylamino- The simplest and most direct method for 1,2,3,4-tetralin.
依据本发明的第三个方案,按下面反应图解3制备结构式(I)的化合物:反应图解3 其中的R1是甲基。According to the third scheme of the present invention, prepare the compound of structural formula (I) according to following reaction scheme 3: Reaction scheme 3 Wherein R 1 is a methyl group.
该方法包括:The method includes:
(a)将4-(2,3-二烷氧基苯基)-2-酮基丁烯酸与氨基甲酸低级烷基酯一起缩合则得到5一(2,3-二烷氧基苯基)-3-烷氧基羰基氨基-2,5-二氢呋喃-2-酮;(a) Condensation of 4-(2,3-dialkoxyphenyl)-2-ketobutenoic acid with lower alkyl carbamate gives 5-(2,3-dialkoxyphenyl )-3-alkoxycarbonylamino-2,5-dihydrofuran-2-one;
(b)还原该缩合产物则得到4-(2,3-二烷氧基苯基)-2-烷氧基羰基氨基丁酸;(b) reducing the condensation product to obtain 4-(2,3-dialkoxyphenyl)-2-alkoxycarbonylaminobutyric acid;
(c)分子内环化则得到5,6-二烷氧基-2-烷氧基羰基氨基-1-四氢萘酮;(c) Intramolecular cyclization then obtains 5,6-dialkoxy-2-alkoxycarbonylamino-1-tetralone;
(d)将该酮基还原则得到5,6-二烷氧基-2-烷氧基羰基氨基-1,2,3,4-四氢化萘;(d) reducing the keto group to obtain 5,6-dialkoxy-2-alkoxycarbonylamino-1,2,3,4-tetralin;
(e)将该氨基甲酸酯还原则得到5,6-二烷氧基-2-甲基氨基-1,2,3,4-四氢化萘。(e) Reduction of the carbamate yields 5,6-dialkoxy-2-methylamino-1,2,3,4-tetralin in principle.
下面详述每一步骤。Each step is detailed below.
第一步骤:该步骤包含将4-(2,3-二烷氧基苯基)-2-氧代-3-丁烯酸与合适的氨基甲酸烷基酯(例如氨基甲酸甲酯)一起缩合,该反应在无水有机溶剂中在存在催化剂(例如对甲苯磺酸)下进行,因此一步就引入了取代的氨基。该反应的产率接近于定量。 First step : This step involves the condensation of 4-(2,3-dialkoxyphenyl)-2-oxo-3-butenoic acid together with a suitable alkyl carbamate (eg methyl carbamate) , the reaction is carried out in an anhydrous organic solvent in the presence of a catalyst (such as p-toluenesulfonic acid), thus introducing the substituted amino group in one step. The yield of this reaction is close to quantitative.
第二步骤:该步骤包含在醇介质中使用催化剂(例如披钯碳)将3-烷氧基羰基氨基-5-(2,3-二烷氧苯基)-2,5-二氢呋喃-2-酮进行催化氢化,因此得到2-烷氧基羰基氨基-4-(2,3-二烷氧基苯基)丁酸。该反应的产率接近于定量。 Second step : This step comprises the use of a catalyst (e.g. palladium on carbon) to convert 3-alkoxycarbonylamino-5-(2,3-dialkoxyphenyl)-2,5-dihydrofuran- The 2-ketone is subjected to catalytic hydrogenation, thus giving 2-alkoxycarbonylamino-4-(2,3-dialkoxyphenyl)butanoic acid. The yield of this reaction is close to quantitative.
在对映选择性条件下可以进行脱氢氨基酸3-烷氧基羰基氨基-5-(2,3-二烷氧基苯基)-2,5-二氢呋喃-2-酮的还原反应,因而得到旋光体2-烷氧基羰基氨基-4-(2,3-二烷氧基苯基)丁酸,由此可得到本发明的另一优越性。例如,通过不对称的氢化作用,特别是使用合适的与任选活性配位体配合的过渡金属配合物作为催化剂,参见R.M.Williams所著的《Synthesis of Optically Active α-Amino Acids》第230-256页(Pergamon Press出版)及所引证的参考文献。The reduction reaction of dehydroamino acid 3-alkoxycarbonylamino-5-(2,3-dialkoxyphenyl)-2,5-dihydrofuran-2-one can be carried out under enantioselective conditions, Thus, the optically active 2-alkoxycarbonylamino-4-(2,3-dialkoxyphenyl)butanoic acid is obtained, whereby another advantage of the present invention can be obtained. For example, by asymmetric hydrogenation, especially using as catalyst a suitable transition metal complex complexed with an optionally active ligand, see Synthesis of Optically Active α-Amino Acids by R.M.Williams pp. 230-256 Page (published by Pergamon Press) and cited references.
第三步骤:该步骤包含将2-烷氧基羰基氨基-4-(2,3-二烷氧基苯基)丁酸环化,则得到2-烷氧基羰基氨基-5,6-二烷氧基-1-四氢萘酮。该分子内酰化反应按常规工序进行,例如通过加热,使用无溶剂的多磷酸,另一个例子是,在室温下使用在合适溶剂中的PCl5和四氯化锡或其它弗瑞德-克来福催化剂(在环化旋光的产物的情况下优选第二种工序,以得到该四氢萘酮的相应对映体)。 The third step : this step includes the cyclization of 2-alkoxycarbonylamino-4-(2,3-dialkoxyphenyl)butanoic acid to obtain 2-alkoxycarbonylamino-5,6-di Alkoxy-1-tetralones. The intramolecular acylation reaction is carried out according to conventional procedures, for example by heating, using solvent-free polyphosphoric acid, another example is using PCl5 and tin tetrachloride or other Friedel-Grade in a suitable solvent at room temperature. Rifle catalyst (the second procedure is preferred in the case of cyclization of optically active products to obtain the corresponding enantiomer of the tetralone).
该步骤的产率也接近于定量。The yield of this step is also close to quantitative.
第四步骤:按常规工序进行该还原反应,对于旋光的化合物,例如也可通过催化氢化(参见上述方法)。产率也接近于定量。 The fourth step : Carry out the reduction reaction according to conventional procedures, for optically active compounds, for example, catalytic hydrogenation can also be used (see the above method). Yields are also close to quantitative.
第五步骤:该步骤包含将氨基甲酸烷基酯基团(特别是甲氧基羰基氨基基团)还原成甲基氨基基团的还原反应,该反应使用化学计算量的合适的还原剂,特别是在合适溶剂(如四氢呋喃)中的氢化铝锂。该方法具有良好的产率(60-70%),并且也可应用于旋光的化合物以得到5,6-二烷氧基-2-烷基氨基-1,2,3,4-四氢化萘的相应对映体。 Fifth step : This step involves the reduction of an alkyl carbamate group (in particular a methoxycarbonylamino group) to a methylamino group using a stoichiometric amount of a suitable reducing agent, in particular is lithium aluminum hydride in a suitable solvent such as tetrahydrofuran. The method has good yields (60-70%) and can also be applied to optically active compounds to give 5,6-dialkoxy-2-alkylamino-1,2,3,4-tetralin corresponding enantiomers of .
第六步骤:该步骤包含用常规(和对映选择性)工序对儿茶酚基团去保护,例如用浓氢溴酸并加热,则得到5,6-二羟基-2-甲基氨基-1,2,3,4-四氢化萘,产率接近于定量。 Sixth step : This step involves deprotection of the catechol group by conventional (and enantioselective) procedures, for example with concentrated hydrobromic acid and heating, then 5,6-dihydroxy-2-methylamino- 1,2,3,4-tetralin, the yield is close to quantitative.
该方案的工序与前面方案的工序相比较难控制且工序较长,但该工序可得到非常高的产率,并且也可适用于得到旋光的化合物。The procedure of this scheme is more difficult to control and longer than that of the previous scheme, but this procedure can obtain very high yields and is also suitable for obtaining optically active compounds.
第四个工序(方案)是以四个步骤进行,从4-(2,3-二甲氧基苯基)-2-氧代-3-丁烯酸开始,并且适用于得到5,6-二羟基-2-氨基-1,2,3,4-四氢化萘。将该第四个方法分成两个基本相同的平行路线(A和B)。The fourth procedure (scheme) is carried out in four steps, starting from 4-(2,3-dimethoxyphenyl)-2-oxo-3-butenoic acid and suitable for obtaining 5,6- Dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene. This fourth method is split into two substantially identical parallel routes (A and B).
依据路线A,按下面反应图解(4)制备结构式(I)的化合物:反应图解4 According to route A, prepare the compound of structural formula (I) by following reaction scheme (4): Reaction scheme 4
该方法包括的步骤如下:The method includes the following steps:
(a)将4-(2,3-二烷氧基苯基)-2-氧代-3-丁烯酸与氨基甲酸苄酯一起缩合,得到3-苄氧基羰基氨基-5-(2,3-二烷氧基苯基)-2,5-二氢呋喃-2-酮;(a) Condensation of 4-(2,3-dialkoxyphenyl)-2-oxo-3-butenoic acid with benzyl carbamate gives 3-benzyloxycarbonylamino-5-(2 , 3-dialkoxyphenyl)-2,5-dihydrofuran-2-one;
(b)将3-苄氧基羰基氨基-5-(2,3-二烷氧基苯基)-2,5-二氢呋喃-2-酮催化还原并同时去保护,则得到2-氨基-4-(2,3-二烷氧基苯基)丁酸;(b) Catalytic reduction of 3-benzyloxycarbonylamino-5-(2,3-dialkoxyphenyl)-2,5-dihydrofuran-2-one and simultaneous deprotection to obtain 2-amino -4-(2,3-dialkoxyphenyl)butanoic acid;
(c)用HBr环化并同时去保护则得到5,6-二羟基-2-氨基-1-四氢萘酮;(c) cyclization with HBr and simultaneous deprotection gives 5,6-dihydroxy-2-amino-1-tetralone;
(d)将2-氨基-5,6-二羟基-1-四氢萘酮还原则得到2-氨基-5,6-二羟基-1,2,3,4-四氢化萘。(d) Reducing 2-amino-5,6-dihydroxy-1-tetralinone to obtain 2-amino-5,6-dihydroxy-1,2,3,4-tetralin.
下面详述每一个步骤:Each step is detailed below:
第一步骤:该步骤包含将4-(2,3-二甲氧基苯基)-2-氧代-3-丁烯酸与氨基甲酸苄酯一起缩合。该反应在无水有机溶剂中及有催化剂(例如对甲苯磺酸)的条件下进行,因此,一步就引入了保护的氨基。该反应的产率接近于定量。 First step : This step involves the condensation of 4-(2,3-dimethoxyphenyl)-2-oxo-3-butenoic acid together with benzyl carbamate. The reaction is carried out in an anhydrous organic solvent with a catalyst (such as p-toluenesulfonic acid), so the protected amino group is introduced in one step. The yield of this reaction is close to quantitative.
第二步骤:该步骤包含将3-苄氧基羰基氨基-5-(2,3-二甲氧基苯基)-2,5-二氢呋喃-2-酮催化氢化,例如在醇介质中用披钯碳作催化剂,因而一步直接得到去保护的2-氨基-4-(2,3-二甲氧基苯基)丁酸。该反应的产率接近于定量。如上所讨论的那样,该反应也可以在对映选择性条件下进行,以得到为旋光体的2-氨基-4-(2,3-二甲氧基苯基)丁酸。 Second step : This step involves the catalytic hydrogenation of 3-benzyloxycarbonylamino-5-(2,3-dimethoxyphenyl)-2,5-dihydrofuran-2-one, e.g. in an alcoholic medium Palladium-on-carbon is used as a catalyst, so deprotected 2-amino-4-(2,3-dimethoxyphenyl)butyric acid can be directly obtained in one step. The yield of this reaction is close to quantitative. As discussed above, this reaction can also be performed under enantioselective conditions to give 2-amino-4-(2,3-dimethoxyphenyl)butanoic acid as the optical form.
第三步骤:该步骤包含氨基酸的分子内酰化的环化,同时使儿茶酚羟基去保护,则得到5,6-二羟基-2-氨基-1-四氢萘酮。该反应例如使用合适的卤代含氢酸(如48%加热的氢溴酸)进行。反应的产率高(约80%)。 The third step : this step includes the cyclization of the intramolecular acylation of the amino acid, and at the same time deprotects the catechol hydroxyl group to obtain 5,6-dihydroxy-2-amino-1-tetralone. The reaction is carried out, for example, using a suitable halogenated hydroacid such as 48% heated hydrobromic acid. The yield of the reaction was high (about 80%).
第四步骤:该步骤包含例如在含水或水醇介质中使用披钯碳作催化剂通过催化氢化将2-氨基-5,6-二羟基-1-四氢萘酮还原,则得到2-氨基-5,6-二羟基-1,2,3,4-四氢化萘。产率接近于定量。 The fourth step : this step comprises, for example, reducing 2-amino-5,6-dihydroxy-1-tetralone by catalytic hydrogenation using palladium-on-carbon as a catalyst in an aqueous or hydroalcoholic medium to obtain 2-amino- 5,6-Dihydroxy-1,2,3,4-tetrahydronaphthalene. The yield is close to quantitative.
另一方面,依据路线B,在第一步骤,在相同条件下将4-(2,3-二甲氧烷基苯基)-2-氧代-3-丁烯酸与氨基甲酸烷基酯(例如氨基甲酸甲酯)一起缩合。On the other hand, according to route B, in the first step, under the same conditions, 4-(2,3-dimethoxyalkylphenyl)-2-oxo-3-butenoic acid and alkyl carbamate (e.g. methyl carbamate) are condensed together.
第二步骤包含在方法3的第二步骤所述条件下将3-烷氧基羰基氨基-5-(2,3-二甲氧基苯基)-2,5-二氢呋喃-2-酮催化氢化。The second step comprises reacting 3-alkoxycarbonylamino-5-(2,3-dimethoxyphenyl)-2,5-dihydrofuran-2-one under the conditions described in the second step of method 3 Catalytic hydrogenation.
第三步骤包含氨基酸分子内酰化的环化,同使儿茶酚羟基和氨基都去保护,则得到5,6-二羟基-2-氨基-1-四氢萘酮。The third step involves the cyclization of the intramolecular acylation of the amino acid with deprotection of both the catechol hydroxyl and amino groups to give 5,6-dihydroxy-2-amino-1-tetralone.
第四步骤按上述反应图解4所述进行。The fourth step is carried out as described in Reaction Scheme 4 above.
该方法因为具有高的产率、易于操作且试剂成本低而引起工业界的特别兴趣,尽管该方法仅限于得到2-氨基-5,6-二羟基-1,2,3,4-四氢化萘。This method is of particular interest to industry because of its high yields, ease of operation, and low reagent cost, although it is limited to obtaining 2-amino-5,6-dihydroxy-1,2,3,4-tetrahydrogenated naphthalene.
应当指出的是,正如在文献中已知的那样,儿茶酚基团尤其是碱性介质中是特别不稳定的,因而需要使用保护基团或成盐化。这包括难以克服的困难,例如当需要该产物的有机盐时。It should be noted that, as is known in the literature, catechol groups are particularly labile, especially in alkaline media, thus requiring the use of protecting groups or salification. This involves formidable difficulties, for example when an organic salt of the product is desired.
下面的实施例用于说明本发明。实施例12-酮基-4-(2,3-二甲氧基苯基)-3-丁烯酸 The following examples illustrate the invention. Example 1 2-keto-4-(2,3-dimethoxyphenyl)-3-butenoic acid
将300ml去离子水和50g氢氧化钾放入3升烧瓶中。搅拌该混合物直至溶解,然后加入150ml乙醇和100g 2,3-二甲氧基苯甲醛。之后,向其滴加60.0g丙酮酸(在约30分钟内)并在35-40℃温度搅拌该混合物约15分钟,然后将其倒入6500ml水中并用约140ml浓HCl将其调至显著地呈酸性pH。将该混合物边搅拌边冷却约30分钟,然后用水洗涤过滤并在60℃于真空下干燥,则得到橙色固体。产率:115g,80%(摩尔),115%(重量);TLC(薄层色谱法分析):二氯甲烷/甲醇/乙酸80/20/2;Rf:0.5;M.P.(熔点):136-138℃。实施例22-甲基氨基-4-(2,3-二甲氧基苯基)丁酸盐酸盐 Put 300ml of deionized water and 50g of potassium hydroxide in a 3 liter flask. The mixture was stirred until dissolved, then 150 ml of ethanol and 100 g of 2,3-dimethoxybenzaldehyde were added. Thereafter, 60.0 g of pyruvic acid was added dropwise thereto (within about 30 minutes) and the mixture was stirred at a temperature of 35-40° C. for about 15 minutes, then poured into 6500 ml of water and brought to a noticeably darker state with about 140 ml of concentrated HCl. acidic pH. The mixture was cooled with stirring for about 30 minutes, then washed with water filtered and dried under vacuum at 60°C to give an orange solid. Yield: 115 g, 80 mole %, 115 weight %; TLC (analysis by thin layer chromatography): dichloromethane/methanol/acetic acid 80/20/2; R f : 0.5; MP (melting point): 136 -138°C. Example 2 2-methylamino-4-(2,3-dimethoxyphenyl)butyric acid hydrochloride
将溶于700ml乙醇中的70.0g 2-酮基-4-(2,3-二甲氧基苯基)-3-丁烯酸(0.30mol)放入氢化器中,然后在氮气氛下加入43.0g 8.03M(0.34mol)甲胺溶液和冰醋酸至pH为8-9,将温度保持在低于25℃。连续搅拌约15分钟,之后加入14.0g Pd/C(约50%湿度),在氢气压力(40psi,室温)下反应6小时。然后用浓HCl将该混合物调至显著地呈酸性pH,过滤并将该溶液蒸发至干燥。取出所得固体并用300ml丙酮加热(50℃)研制,之后将其在搅拌下冷却、过滤并在40℃真空下干燥。产率:51g,60%(摩尔),73%(重量);TLC:二氯甲烷/甲醇/乙酸75/20/10;Rf=0.5;展开剂:茚三酮。M.P.=165-166℃。实施例34-(2,3-二甲氧基苯基)-2-(N-甲基-N-苄氧基羰基氨 基)丁酸 Put 70.0 g of 2-keto-4-(2,3-dimethoxyphenyl)-3-butenoic acid (0.30 mol) dissolved in 700 ml of ethanol into the hydrogenator, and then add 43.0 g of 8.03M (0.34 mol) methylamine solution and glacial acetic acid to pH 8-9, keeping the temperature below 25°C. Stirring was continued for about 15 minutes, and then 14.0 g of Pd/C (about 50% humidity) was added and reacted under hydrogen pressure (40 psi, room temperature) for 6 hours. The mixture was then brought to a markedly acidic pH with concentrated HCl, filtered and the solution evaporated to dryness. The resulting solid was removed and triturated with 300 ml of acetone under heat (50°C), after which it was cooled with stirring, filtered and dried under vacuum at 40°C. Yield: 51 g, 60% (mole), 73% (weight); TLC: dichloromethane/methanol/acetic acid 75/20/10; R f =0.5; developing solvent: ninhydrin. MP = 165-166°C. Example 3 4-(2,3-dimethoxyphenyl)-2-(N-methyl-N- benzyloxycarbonylamino )butanoic acid
将14.0gα-甲基氨基-4-(2,3-二甲氧基苯基)丁酸盐酸盐(0.048mol)和24ml的4N NaOH放入250ml烧瓶中,将所得溶液冷却至约0℃,然后,同时但分别地向该溶液中滴加9.1g氯甲酸苄酯(0.053mol)和13.5ml 4N NaOH,以将该溶液总保持为微碱性,冷却至T<20℃,然后在室温保持约2小时。用甲醇HCl稀释该反应混合物,用100ml乙醚(2×50ml)洗涤,之后用约30ml 2N HCl显著地酸化。并用150ml乙酸乙酯萃取(3×50ml)。将该有机相通过硫酸钠干燥、过滤并蒸发至干燥(40℃),则得到透明的稠状黄色油,它可直接用于后续步骤。产率:18.5g,约100%(摩尔),约132%(重量);TLC:二氯甲烷/甲醇90/10<;Rf=0.88。按相同的步骤用氯甲酸乙酯也可得到氨基的保护,并具有类似的结果。实施例44-〔2-(2,3-二甲氧基苯基)-乙基〕-N-甲基-2,5-噁 唑烷二酮 Put 14.0 g of α-methylamino-4-(2,3-dimethoxyphenyl) butyrate hydrochloride (0.048 mol) and 24 ml of 4N NaOH into a 250 ml flask, and cool the resulting solution to about 0 °C , then, simultaneously but separately dropwise added 9.1 g benzyl chloroformate (0.053 mol) and 13.5 ml 4N NaOH to the solution to keep the solution slightly alkaline, cooled to T<20° C., and then at room temperature Leaves on for about 2 hours. The reaction mixture was diluted with methanolic HCl, washed with 100 ml diethyl ether (2 x 50 ml), and then significantly acidified with about 30 ml 2N HCl. And extracted with 150ml ethyl acetate (3 x 50ml). The organic phase was dried over sodium sulfate, filtered and evaporated to dryness (40°C) to give a clear thick yellow oil which was used directly in the next step. Yield: 18.5 g, about 100% by mole, about 132% by weight; TLC: dichloromethane/methanol 90/10<; R f =0.88. The protection of the amino group can also be obtained with ethyl chloroformate by the same procedure with similar results. Example 4 4-[2-(2,3-dimethoxyphenyl)-ethyl]-N-methyl-2,5- oxazolidinedione
将18.5g 4-(2,3-二甲氧苯基)-2-(N-甲基-N-苄氧基羰基-氨基)-丁酸(0.048mol)和28.7g亚硫酰氯放入250ml圆底烧瓶中,回流2小时,然后在真空下蒸馏出亚硫酰氯直至得到稠状油。将该油取出放入100ml已烷中,搅拌直至固化,之后将其滗析并用100ml多的己烷研制,过滤以及在30℃真空下干燥,则得到细的晶状粉末。产率:12.5g,93%(摩尔),68%(重量)。实施例55,6-二甲氧基-2-甲基氨基-1-四氢萘酮盐酸盐 Put 18.5g of 4-(2,3-dimethoxyphenyl)-2-(N-methyl-N-benzyloxycarbonyl-amino)-butyric acid (0.048mol) and 28.7g of thionyl chloride into 250ml In a round bottom flask, reflux for 2 hours, then distill off thionyl chloride under vacuum until a thick oil is obtained. The oil was taken out in 100ml of hexane, stirred until solidified, after which it was decanted and triturated with 100ml more hexane, filtered and dried under vacuum at 30°C to give a fine crystalline powder. Yield: 12.5 g, 93% by mole, 68% by weight. Example 5 5,6-dimethoxy-2-methylamino-1-tetralone hydrochloride
在氮气氛下,将在200ml二氯甲烷中的12.5g无水氯化铝(0.094mol)放入3升圆底烧瓶中,冷却至0℃,然后在约10分钟内将溶于200ml二氯甲烷中的4-〔2-(2,3-二甲氧基苯基)-乙基〕-N-甲基-2,5-噁唑烷二酮加入,保持T<10℃。在T<10℃下将该混合物搅拌30分钟,然后于室温搅拌1小时。将该混合物再次冷至0℃,并向其中滴加200ml水,保持T<20℃,之后于室温搅拌该混合物约1小时,分离出有机相,用水萃取(3×400ml)。用400ml 20% KHCO3溶液将合并的水液相缓慢地碱化,并用3×400ml氯仿萃取。之后,将该有机相通过硫酸钠干燥、过滤并蒸发至干燥,则得到蜡状化合物,将其取出放入50℃的150ml丙酮中,搅拌1小时并静置过夜,之后过滤并于室温真空干燥。产率:8.2g,67%(摩尔);TLC:二氯甲烷/甲醇,90/10;Rf=0.35;M.P.=208-209℃。实施例65,6-二甲氧基-2-甲基氨基-1,2,3,4-四氢化萘盐酸盐 Under a nitrogen atmosphere, put 12.5 g of anhydrous aluminum chloride (0.094 mol) in 200 ml of dichloromethane into a 3-liter round bottom flask, cool to 0°C, and dissolve in 200 ml of dichloromethane in about 10 minutes. 4-[2-(2,3-Dimethoxyphenyl)-ethyl]-N-methyl-2,5-oxazolidinedione in methane was added keeping T<10°C. The mixture was stirred at T<10°C for 30 minutes, then at room temperature for 1 hour. The mixture was cooled to 0°C again, and 200ml of water was added dropwise thereto, keeping T<20°C, after which the mixture was stirred at room temperature for about 1 hour, and the organic phase was separated and extracted with water (3×400ml). The combined aqueous phases were slowly basified with 400 ml of 20% KHCO 3 solution and extracted with 3 x 400 ml of chloroform. Afterwards, the organic phase was dried over sodium sulfate, filtered and evaporated to dryness to obtain a waxy compound, which was taken out into 150 ml of acetone at 50° C., stirred for 1 hour and allowed to stand overnight, then filtered and dried under vacuum at room temperature . Yield: 8.2 g, 67 mol %; TLC: dichloromethane/methanol, 90/10; Rf = 0.35; MP = 208-209°C. Example 6 5,6-dimethoxy-2-methylamino-1,2,3,4-tetralin hydrochloride
将14.0g 5,6-二甲氧基-2-甲基氨基-1-四氢萘酮盐酸盐(0.051mol)、400ml无水乙醇、10ml 1M甲醇HCl和4.0g 5% Pd/c放入高压釜(50%湿度)中,然后通过搅拌24小时将该混合物氢化(压力P约7个大气压,T=80℃)。将该混合物洗涤,用热甲醇彻底洗涤该滤饼。然后将乙醇溶液蒸发至干燥。将所得固体取出放入150ml丙酮中,之后将沉淀物过滤并在60℃真空下干燥。产率:10.8g,82%(摩尔),77%(重量);M.P.=219-220℃。实施例75,6-二羟基-2-甲基氨基-1,2,3,4-四氢化萘·HClPut 14.0g of 5,6-dimethoxy-2-methylamino-1-tetralone hydrochloride (0.051mol), 400ml of absolute ethanol, 10ml of 1M methanolic HCl and 4.0g of 5% Pd/c into an autoclave (50% humidity) and then hydrogenate the mixture by stirring for 24 hours (pressure P about 7 atm, T=80° C.). The mixture was washed and the filter cake was washed thoroughly with hot methanol. The ethanol solution was then evaporated to dryness. The resulting solid was taken up in 150 ml of acetone, after which the precipitate was filtered and dried under vacuum at 60°C. Yield: 10.8 g, 82% by mole, 77% by weight; M.P. = 219-220°C. Example 75, 6-dihydroxy-2-methylamino-1,2,3,4-tetralin·HCl
在干燥氮气的弱气流下伴随搅拌将41.4g干AlCl3(310.4mol)、230ml甲苯和20.0g 5,6-二甲氧基-2-甲基氨基-1,2,3,4-四氢化萘HCl(77.6mol)放入4颈圆底烧瓶中。将温度升至80℃则得到可搅拌的棕色混合物,将其于80℃放置4小时,之后冷却至室温并倒入冰水中(总量约1000ml)。将水相分离并在真空下蒸发(T约80℃)。在室温将该稍白色的固体在750ml无水乙醇中研制,之后于60℃干燥。产率:16.1g,90%(摩尔),80%(重量);M.P.>280℃。实施例85,6-二羟基-2-甲基氨基-1-四氢萘酮氢溴化物(bromidrato) 41.4 g of dry AlCl 3 (310.4 mol), 230 ml of toluene and 20.0 g of 5,6-dimethoxy-2-methylamino-1,2,3,4-tetrahydrogenated with stirring under a weak stream of dry nitrogen Naphthalene HCl (77.6 mol) was placed in a 4 neck round bottom flask. Raising the temperature to 80°C gave a stirrable brown mixture which was left at 80°C for 4 hours before being cooled to room temperature and poured into ice water (total amount about 1000ml). The aqueous phase was separated and evaporated under vacuum (T about 80°C). The off-white solid was triturated in 750 ml of absolute ethanol at room temperature and then dried at 60°C. Yield: 16.1 g, 90% by mole, 80% by weight; MP>280°C. Example 8 5,6-dihydroxy-2-methylamino-1-tetralone hydrobromide (bromidrato)
伴随搅拌将15.0g酸性2-甲基氨基-4-(2,3-二甲氧基苯基)-丁酸盐酸盐(52mmol)和100.0ml 48% HBr水溶液(900mmol)的混合物回流3小时,之后冷却至0℃,通过过滤将所得沉淀物回收,用丙酮(50ml)洗涤并在60℃真空下干燥。产率:13.5g;TLC:CH2Cl2/CH3OH/CH3COOH 70/20/10(FeCl3/K3Fe(CN)6);M.P.:240-243℃。实施例95,6-二羟基-2-甲基氨基-1,2,3,4-四氢化萘盐酸盐 A mixture of 15.0 g of acidic 2-methylamino-4-(2,3-dimethoxyphenyl)-butyric acid hydrochloride (52 mmol) and 100.0 ml of 48% aqueous HBr (900 mmol) was refluxed for 3 hours with stirring , after cooling to 0°C, the resulting precipitate was recovered by filtration, washed with acetone (50 ml) and dried at 60°C under vacuum. Yield: 13.5 g; TLC: CH 2 Cl 2 /CH 3 OH/CH 3 COOH 70/20/10 (FeCl 3 /K 3 Fe(CN) 6 ); MP: 240-243°C. Example 9 5,6-dihydroxy-2-methylamino-1,2,3,4-tetralin hydrochloride
在高压釜(哈斯特洛伊耐蚀镍基合金)中(20atm.,80℃)将10.0g 5,6-二羟基-2-甲基氨基-1-四氢萘酮氢溴化物、2.0g Pd/C 5%、90ml水和10ml 37% HCl的混合物氢化8-9小时,然后用热水洗涤过滤物。在真空下将该水溶液浓缩,并用100ml 37%盐酸热研制该所得固体,之后冷至0℃并过滤。将所得固体从丙酮中重结晶并在60℃真空下干燥。产率:7.4g。实施例103-甲氧基羰基氨基-5-(2,3-二甲氧基苯基)-2,5-二氢呋 喃-2-酮 In an autoclave (Hasterloy) (20atm., 80°C), 10.0g of 5,6-dihydroxy-2-methylamino-1-tetralone hydrobromide, 2.0g of Pd A mixture of /C 5%, 90 ml water and 10 ml 37% HCl was hydrogenated for 8-9 hours, then the filtrate was washed with hot water. The aqueous solution was concentrated in vacuo and the resulting solid was triturated hot with 100 ml of 37% hydrochloric acid before being cooled to 0°C and filtered. The resulting solid was recrystallized from acetone and dried under vacuum at 60°C. Yield: 7.4 g. Example 10 3-methoxycarbonylamino-5-(2,3-dimethoxyphenyl)-2,5- dihydrofuran - 2-one
将300g 2-酮基-4-(2,3-二甲氧基苯基)-3-丁烯酸、860ml甲苯、13.4g对甲苯磺酸和133.8g氨基甲酸甲酯放入在油浴中的6升4颈圆底烧瓶中,伴随搅拌将该混合物加热至105℃保温4小时;通过共沸去除所存的水,将该混合物过滤,并在真空下将该溶液蒸发至干燥,之后用1260ml Et2O研制该残余物约2小时,将该残余物过滤,用石油醚(40-70℃)洗涤过滤物并在60℃真空下干燥。得到313.00g产物。(产率为94%)。实施例112-甲氧基羰基氨基-4-(2,3-二甲氧基苯基)丁酸 Put 300g of 2-keto-4-(2,3-dimethoxyphenyl)-3-butenoic acid, 860ml of toluene, 13.4g of p-toluenesulfonic acid and 133.8g of methyl carbamate in an oil bath In a 6-liter 4-necked round-bottom flask, the mixture was heated to 105°C with stirring for 4 hours; the remaining water was removed by azeotropy, the mixture was filtered, and the solution was evaporated to dryness under vacuum, and then used with 1260ml The residue was triturated with Et2O for about 2 hours, the residue was filtered, the filtrate was washed with petroleum ether (40-70°C) and dried under vacuum at 60°C. 313.00 g of product were obtained. (94% yield). Example 11 2-methoxycarbonylamino-4-(2,3-dimethoxyphenyl)butanoic acid
将150g 3-甲氧基羰基氨基-5-(2,3-二甲氧基苯基)-2,5-二氢呋喃-2-酮和1190ml CH3OH放入帕尔(parr)氢化器的2000ml烧瓶中,之后伴随搅拌将其加热直至完全溶解(T约64℃);加入30g 5% Pd/C,在35psi下开始氢化直至不再吸收H2(约60分钟)。用TLC检查该原料化合物的消失,之后,用Celite(硅藻土)过滤该混合物并蒸发该滤液至干燥,通过伴随搅拌加入乙醚和石油醚将所得的油沉淀,继续搅拌约30分钟,然后将该混合物过滤并在60℃真空下干燥。得141.6g产物。(产率:93%)。实施例122-甲氧基羰基氨基-5,6-二甲氧基-1-四氢萘酮 Put 150g of 3-methoxycarbonylamino-5-(2,3-dimethoxyphenyl)-2,5-dihydrofuran-2-one and 1190ml CH3OH in a parr hydrogenator 2000ml flask, then heated with stirring until completely dissolved (T about 64°C); add 30g 5% Pd/C, start hydrogenation at 35psi until no more H2 uptake (about 60 minutes). The disappearance of the starting compound was checked by TLC, after which the mixture was filtered through Celite (diatomaceous earth) and the filtrate was evaporated to dryness, the resulting oil was precipitated by adding diethyl ether and petroleum ether with stirring, stirring was continued for about 30 minutes, and then The mixture was filtered and dried under vacuum at 60°C. 141.6 g of product were obtained. (Yield: 93%). Example 12 2-methoxycarbonylamino-5,6-dimethoxy-1-tetralone
将610g多磷酸放入5000ml反应器中,加热至60℃,之后,伴随强机械搅拌加入61g 2-甲氧基羰基氨基-4-(2,3-二甲氧基苯基)-丁酸。20分钟后,用水(2000ml)稀释该搅拌的混合物,再于室温继续搅拌60分钟。将所得混合物过滤并将固体溶于3000ml氯仿中。用水洗涤该所得溶液直至洗液呈中性pH。610g polyphosphoric acid is put into 5000ml reactor, is heated to 60 ℃, afterwards, adds 61g 2-methoxycarbonylamino-4-(2,3-dimethoxyphenyl)-butyric acid with strong mechanical stirring. After 20 minutes, the stirred mixture was diluted with water (2000ml) and stirring was continued for 60 minutes at room temperature. The resulting mixture was filtered and the solid was dissolved in 3000ml chloroform. The resulting solution was washed with water until the washings were at neutral pH.
将该有机相通过硫酸钠干燥、过滤并在真空下蒸发至干燥。将该浅棕色固体残余物在300ml乙醚和50ml石油醚中研制约2小时,之后过滤并在60℃真空下干燥,则得到粉末状黄棕色固体。产率:51.2g,89.5%(摩尔),84.0%(重量);TLC:二氯甲烷95-甲醇5;Rf=0.95。实施例132-甲氧基羰基氨基-5,6-二甲氧基-1,2,3,4-四氢化萘 The organic phase was dried over sodium sulfate, filtered and evaporated to dryness under vacuum. The light brown solid residue was triturated in 300 ml diethyl ether and 50 ml petroleum ether for about 2 hours before being filtered and dried under vacuum at 60°C to give a powdery yellow brown solid. Yield: 51.2 g, 89.5 mol%, 84.0 wt %; TLC: dichloromethane 95-methanol 5; Rf = 0.95. Example 13 2-methoxycarbonylamino-5,6-dimethoxy-1,2,3,4-tetralin
伴随搅拌将50g 2-甲氧基羰基氨基-5,6-二甲氧基-1-四氢萘酮溶解在1000ml烧瓶中的500ml甲醇中,加入20g 5% Pd/C,之后将其整个放入在80℃的氢气气氛且压力为25大气压条件下的高压釜(Hastelloy)中,伴随搅拌,反应6小时,之后将该混合物在高压釜中冷却至约30℃。用Celite(硅藻土)过滤该混合物并将滤液在真空下蒸发至干燥。将所得白色固体在60℃的400ml正己烷中研制,然后伴随搅拌冷却至约30℃,过滤并在60℃真空下干燥,则得到稍白色的固体。产率:40.6g,85.5%(摩尔),81.2%(重量);TLC:二氯甲烷95-甲醇5;Rf=0.76;M.P.=108.7-111.4℃。实施例145,6-二甲氧基-2-甲基氨基-1,2,3,4-四氢化萘盐酸盐 50 g of 2-methoxycarbonylamino-5,6-dimethoxy-1-tetralone was dissolved in 500 ml of methanol in a 1000 ml flask with stirring, 20 g of 5% Pd/C was added and the whole was put Into an autoclave (Hastelloy) under a hydrogen atmosphere of 80° C. and a pressure of 25 atmospheres, with stirring, to react for 6 hours, and then cool the mixture to about 30° C. in the autoclave. The mixture was filtered through Celite (diatomaceous earth) and the filtrate was evaporated to dryness under vacuum. The resulting white solid was triturated in 400 ml of n-hexane at 60°C, then cooled to about 30°C with stirring, filtered and dried under vacuum at 60°C to give a slightly white solid. Yield: 40.6 g, 85.5 mol%, 81.2 wt %; TLC: dichloromethane 95-methanol 5; Rf = 0.76; MP = 108.7-111.4°C. Example 14 5,6-dimethoxy-2-methylamino-1,2,3,4-tetralin hydrochloride
将13.5g氢化铝锂和250ml无水四氢呋喃放入1000ml圆底烧瓶中搅拌15分钟,然后缓慢滴加溶于350ml无水四氢呋喃中的80g 2-甲氧基羰基氨基-5,6-二甲氧基-1,2,3,4-四氢化萘以将温度保持在约60℃。继续搅拌15分钟,并过滤该混合物。将该滤液冷却至约0℃,伴随搅拌加入水(1000ml),将温度保持在约30℃。将该反应混合物过滤并用氯仿萃取,用硫酸钠干燥该有机相,这硫酸钠干燥过滤的有机相,过滤并用甲醇HCl酸化。将所得溶液搅拌约30分钟,之后蒸发至干燥。将所得残余物在60℃的350ml乙腈中研制,伴随搅拌冷却至约4℃,之后过滤并在50℃真空下干燥,则得到白色固体。产率:40.7g,52.4%(摩尔),50.9%(重量)。实施例155,6-二羟基-2-甲基氨基-1,2,3,4-四氢化萘盐酸盐 Put 13.5g of lithium aluminum hydride and 250ml of anhydrous tetrahydrofuran into a 1000ml round bottom flask and stir for 15 minutes, then slowly add 80g of 2-methoxycarbonylamino-5,6-dimethoxy in 350ml of anhydrous tetrahydrofuran dropwise 1,2,3,4-tetralin to maintain the temperature at about 60°C. Stirring was continued for 15 minutes, and the mixture was filtered. The filtrate was cooled to about 0°C and water (1000ml) was added with stirring, maintaining the temperature at about 30°C. The reaction mixture was filtered and extracted with chloroform, the organic phase was dried over sodium sulfate, the filtered organic phase was dried over sodium sulfate, filtered and acidified with methanolic HCl. The resulting solution was stirred for about 30 minutes before being evaporated to dryness. The resulting residue was triturated in 350 ml of acetonitrile at 60°C, cooled to about 4°C with stirring, then filtered and dried under vacuum at 50°C to give a white solid. Yield: 40.7 g, 52.4 mole %, 50.9 weight %. Example 15 5,6-dihydroxy-2-methylamino-1,2,3,4-tetralin hydrochloride
将在水中(45ml)的2-甲基氨基-5,6-二羟基-1,2,3,4-四氢化萘(5g)的悬浮液加入到用硫酸钠饱和的碳酸钾(2.5g)水溶液(25ml)中。将该混合物搅拌几分钟,将所形成的固体过滤并用一些水和丙酮洗涤,之后在室温真空下干燥,则得到3.8g的产物。A suspension of 2-methylamino-5,6-dihydroxy-1,2,3,4-tetralin (5 g) in water (45 ml) was added to potassium carbonate (2.5 g) saturated with sodium sulfate aqueous solution (25ml). The mixture was stirred for a few minutes and the solid formed was filtered and washed with some water and acetone before drying under vacuum at room temperature to give 3.8 g of product.
1H-NMR(DMSO-d6):1.40ppm(m,1H,H3ax),1.95(m,1H,H3eq),2.40(s,3H,N-Me),2.3-3.0(m,5H,H4,H2,H1),5.0-6.0(br,2H,Or-H),6.45(d,1H,H7),6.56(d,1H,H8)。 1 H-NMR (DMSO-d6): 1.40ppm (m, 1H, H3ax), 1.95 (m, 1H, H3eq), 2.40 (s, 3H, N-Me), 2.3-3.0 (m, 5H, H4, H2, H1), 5.0-6.0 (br, 2H, Or-H), 6.45 (d, 1H, H7), 6.56 (d, 1H, H8).
EI/MS(70ev):m/和193(M+)。实施例16a)(-)-2-甲氧基羰基氨基-4-(2,3-二甲氧基苯基)-丁酸 EI/MS (70ev): m/ and 193 (M + ). Example 16 a) (-)-2-methoxycarbonylamino-4-(2,3-dimethoxyphenyl)-butanoic acid
将在无氧甲醇(0.25M)中的3-甲氧基羰基氨基-5-(2,3-二甲氧基苯基)-2,5-二氢呋喃-2-酮(500mg,1.7mmol)的溶液放入帕尔氢化器中,加入催化剂,即带有1,5-环辛二烯和1,1′-(1,2-亚苯基)双〔2,5-二乙基〕二磷戊环(S,S)的4-(甲基苯基)磺酸铑化合物〔(SS)-EtDiPhosRh(COD)OTs〕(1.5(μmol),然后在氢气压力(30psi)下于室温将该混合物搅拌1.5小时。3-Methoxycarbonylamino-5-(2,3-dimethoxyphenyl)-2,5-dihydrofuran-2-one (500mg, 1.7mmol) in oxygen-free methanol (0.25M) ) solution into the Parr hydrogenator, adding the catalyst, namely with 1,5-cyclooctadiene and 1,1'-(1,2-phenylene)bis[2,5-diethyl] The 4-(methylphenyl) rhodium sulfonate compound [(SS)-EtDiPhosRh(COD)OTs] (1.5 (μmol) of diphospholane (S, S) is then placed at room temperature under hydrogen pressure (30psi). The mixture was stirred for 1.5 hours.
将该混合物过滤,并在真空下将该滤液蒸发,则得到约500mg的产物(%e.e(NMR=95))。The mixture was filtered and the filtrate was evaporated in vacuo to give about 500 mg of product (% e.e (NMR=95)).
通过结晶将该产物进一步纯化。The product was further purified by crystallization.
进行NMR分析(300Hz,CDCl3,在有R(+)-2-甲氧基-α-三氟甲基苯基乙酸下,在3,842ppm((-)对映体)和3,838ppm((+)对映体)处的信号。(b)(+)-2-甲氧基羰基氨基-4-(2,3-二甲氧苯基)-丁酸 NMR analysis (300 Hz, CDCl 3 , in the presence of R(+)-2-methoxy-α-trifluoromethylphenylacetic acid at 3,842 ppm ((-) enantiomer) and 3,838 ppm ((+ ) enantiomer). (b) (+)-2-methoxycarbonylamino-4-(2,3-dimethoxyphenyl)-butanoic acid
将在无氧甲醇(0.25M)中的3-甲氧基羰基氨基-5-(2,3-二甲氧基苯基)-2,5-二氢呋喃-2-酮(500mg,1.7mmol)的溶液放入帕尔氢化器中,加入催化剂,即带有1,5-环辛二烯和1,1′-(1,2-亚苯基)双〔2,5-二乙基〕二磷戊环(R,R)的4-(甲基苯基)磺酸铑化合物〔(RR)-EtDiPhosRh(COD)OTs〕(1.5(μmol),然后在氢气压力(30psi)下于室温将该混合物搅拌1.5小时。3-Methoxycarbonylamino-5-(2,3-dimethoxyphenyl)-2,5-dihydrofuran-2-one (500mg, 1.7mmol) in oxygen-free methanol (0.25M) ) solution into the Parr hydrogenator, adding the catalyst, namely with 1,5-cyclooctadiene and 1,1'-(1,2-phenylene)bis[2,5-diethyl] The 4-(methylphenyl) rhodium sulfonate compound [(RR)-EtDiPhosRh(COD)OTs] (1.5 (μmol) of diphospholane (R, R) is then placed at room temperature under hydrogen pressure (30psi). The mixture was stirred for 1.5 hours.
将该混合物过滤,并在真空下将该滤液蒸发,则得到500mg的产物(%e.e(NMR)=92)。The mixture was filtered and the filtrate was evaporated under vacuum to give 500 mg of product (% e.e (NMR) = 92).
通过结晶将该产物进一步纯化。The product was further purified by crystallization.
NMR分析(300Hz,CDCl3,在有R(+)-α-甲氧基-α-三氟甲基苯基乙酸下,在3,842ppm((-)对映体)和3,838((+)对映体)处的信号)。实施例17(+)-2-氨基-4-(2,3-二甲氧基氨基)-丁酸 NMR analysis (300Hz, CDCl 3 , in the presence of R(+)-α-methoxy-α-trifluoromethylphenylacetic acid, at 3,842 ppm ((-) enantiomer) and 3,838 ((+) enantiomer) at the signal). Example 17 (+)-2-amino-4-(2,3-dimethoxyamino)-butyric acid
将在无氧甲醇(0.25M)中的3-苄氧基羰基氨基-5-(2,3-二甲氧基苯基)-2,5-二氢呋喃-2-酮(500mg,1.35mmol)的溶液放入帕尔氢化器中,加入催化剂,即带有1,5-环辛二烯和1,1′-(1,2-亚苯基)双〔2,5-二乙基〕二磷戊环(R,R)的4-(甲基苯基)磺酸铑化合物〔(RR)-EtDiPhosRh(COD)OTs〕(1.3(μmol),然后在氢气压力(30psi)下于室温将该混合物搅拌3小时。3-Benzyloxycarbonylamino-5-(2,3-dimethoxyphenyl)-2,5-dihydrofuran-2-one (500mg, 1.35mmol) in oxygen-free methanol (0.25M) ) solution into the Parr hydrogenator, adding the catalyst, namely with 1,5-cyclooctadiene and 1,1'-(1,2-phenylene)bis[2,5-diethyl] The 4-(methylphenyl) rhodium sulfonate compound [(RR)-EtDiPhosRh(COD)OTs] (1.3 (μmol) of diphospholane (R, R), then under hydrogen pressure (30psi) at room temperature The mixture was stirred for 3 hours.
将该混合物过滤,并在真空下将该滤液蒸发,则得到320mg的产物(%e.e(NMR)=75))。The mixture was filtered and the filtrate was evaporated in vacuo to give 320 mg of product (% e.e (NMR) = 75)).
通过结晶将该产物进一步纯化。进行NRM分析:在3.34ppm((-)对映体)和3.22ppm((+)对映体)处的信号。The product was further purified by crystallization. NRM analysis was performed: signals at 3.34 ppm ((-) enantiomer) and 3.22 ppm ((+) enantiomer).
Claims (4)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000802A/1994 | 1994-04-26 | ||
| ITMI940802A IT1269584B (en) | 1994-04-26 | 1994-04-26 | PROCEDURE FOR THE PREPARATION OF 5,6-DIHYDROXY-2-AMINO-1,2,3,4- TETRAIDRONAFTALENE DERIVATIVES |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95192770A Division CN1073984C (en) | 1994-04-26 | 1995-04-13 | Process for preparing 5,6-dihydroxy-2-amino-1,2,3,4-tetralin derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1278528A true CN1278528A (en) | 2001-01-03 |
| CN1137085C CN1137085C (en) | 2004-02-04 |
Family
ID=11368733
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95192770A Expired - Fee Related CN1073984C (en) | 1994-04-26 | 1995-04-13 | Process for preparing 5,6-dihydroxy-2-amino-1,2,3,4-tetralin derivatives |
| CN00103696A Pending CN1278526A (en) | 1994-04-26 | 2000-02-29 | Process for preparation of 5,6-dihydroxyl-2-amino-1,2,3,4-tetrahydronaphthalene derivatives |
| CN00103697A Pending CN1278527A (en) | 1994-04-26 | 2000-02-29 | Process for preparation of 5,6-dihydrxyl-2-amino-1,2,3,4-tetrahydronaphthalene derivatives |
| CNB00103698XA Expired - Fee Related CN1137085C (en) | 1994-04-26 | 2000-02-29 | Method for preparing 5,6-dihydroxy-2-amino-1,2,3,4-tetralin |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95192770A Expired - Fee Related CN1073984C (en) | 1994-04-26 | 1995-04-13 | Process for preparing 5,6-dihydroxy-2-amino-1,2,3,4-tetralin derivatives |
| CN00103696A Pending CN1278526A (en) | 1994-04-26 | 2000-02-29 | Process for preparation of 5,6-dihydroxyl-2-amino-1,2,3,4-tetrahydronaphthalene derivatives |
| CN00103697A Pending CN1278527A (en) | 1994-04-26 | 2000-02-29 | Process for preparation of 5,6-dihydrxyl-2-amino-1,2,3,4-tetrahydronaphthalene derivatives |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US5710336A (en) |
| EP (1) | EP0788472B1 (en) |
| JP (1) | JPH10504519A (en) |
| KR (1) | KR100336703B1 (en) |
| CN (4) | CN1073984C (en) |
| AT (1) | ATE195115T1 (en) |
| AU (1) | AU696561B2 (en) |
| BR (1) | BR9507857A (en) |
| CA (1) | CA2188759A1 (en) |
| DE (1) | DE69518252T2 (en) |
| DK (1) | DK0788472T3 (en) |
| ES (1) | ES2150564T3 (en) |
| FI (1) | FI964278L (en) |
| GR (1) | GR3034709T3 (en) |
| HU (1) | HU221025B1 (en) |
| IL (1) | IL113451A (en) |
| IT (1) | IT1269584B (en) |
| MX (1) | MX9605090A (en) |
| NO (1) | NO307139B1 (en) |
| NZ (1) | NZ284474A (en) |
| PT (1) | PT788472E (en) |
| WO (1) | WO1995029147A1 (en) |
| ZA (1) | ZA953255B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1269584B (en) * | 1994-04-26 | 1997-04-08 | Chiesi Farma Spa | PROCEDURE FOR THE PREPARATION OF 5,6-DIHYDROXY-2-AMINO-1,2,3,4- TETRAIDRONAFTALENE DERIVATIVES |
| IL152751A0 (en) * | 2000-05-12 | 2003-06-24 | Chiesi Farma Spa | Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them |
| US8375404B2 (en) * | 2008-12-30 | 2013-02-12 | The Nielsen Company (Us), Llc | Methods and apparatus to enforce a power off state of an audience measurement device during shipping |
| WO2012021629A2 (en) | 2010-08-11 | 2012-02-16 | Philadelphia Health & Education Corporation | Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease |
| CN110105213B (en) * | 2019-06-06 | 2022-03-25 | 唐山师范学院 | Synthesis method of (E) -2- (naphthyl-1-oxymethyl) -2-dioctyl olefine acid-8-ester |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2653765B1 (en) * | 1989-10-31 | 1993-08-06 | Midy Spa | PROCESS FOR THE ENANTIOSELECTIVE PREPARATION OF 2-AMINOTETRALINES. |
| IT1251877B (en) * | 1991-09-26 | 1995-05-26 | Zambon Spa | PROCESS FOR THE PREPARATION OF 2-AMINO-5,6 DIMETOXY-TETRALINE |
| IT1269584B (en) * | 1994-04-26 | 1997-04-08 | Chiesi Farma Spa | PROCEDURE FOR THE PREPARATION OF 5,6-DIHYDROXY-2-AMINO-1,2,3,4- TETRAIDRONAFTALENE DERIVATIVES |
-
1994
- 1994-04-26 IT ITMI940802A patent/IT1269584B/en active IP Right Grant
-
1995
- 1995-04-13 FI FI964278A patent/FI964278L/en not_active IP Right Cessation
- 1995-04-13 KR KR1019960705873A patent/KR100336703B1/en not_active Expired - Fee Related
- 1995-04-13 AT AT95916655T patent/ATE195115T1/en not_active IP Right Cessation
- 1995-04-13 BR BR9507857A patent/BR9507857A/en not_active Application Discontinuation
- 1995-04-13 ES ES95916655T patent/ES2150564T3/en not_active Expired - Lifetime
- 1995-04-13 JP JP7527320A patent/JPH10504519A/en not_active Ceased
- 1995-04-13 EP EP95916655A patent/EP0788472B1/en not_active Expired - Lifetime
- 1995-04-13 NZ NZ284474A patent/NZ284474A/en unknown
- 1995-04-13 DE DE69518252T patent/DE69518252T2/en not_active Expired - Fee Related
- 1995-04-13 MX MX9605090A patent/MX9605090A/en not_active IP Right Cessation
- 1995-04-13 US US08/722,227 patent/US5710336A/en not_active Expired - Fee Related
- 1995-04-13 CA CA002188759A patent/CA2188759A1/en not_active Abandoned
- 1995-04-13 HU HU9602934A patent/HU221025B1/en not_active IP Right Cessation
- 1995-04-13 DK DK95916655T patent/DK0788472T3/en active
- 1995-04-13 CN CN95192770A patent/CN1073984C/en not_active Expired - Fee Related
- 1995-04-13 PT PT95916655T patent/PT788472E/en unknown
- 1995-04-13 WO PCT/EP1995/001406 patent/WO1995029147A1/en not_active Ceased
- 1995-04-13 AU AU23075/95A patent/AU696561B2/en not_active Ceased
- 1995-04-20 IL IL11345195A patent/IL113451A/en not_active IP Right Cessation
- 1995-04-21 ZA ZA953255A patent/ZA953255B/en unknown
-
1996
- 1996-10-24 NO NO964522A patent/NO307139B1/en not_active IP Right Cessation
-
1997
- 1997-11-03 US US08/962,706 patent/US5936125A/en not_active Expired - Fee Related
-
1999
- 1999-06-04 US US09/325,350 patent/US6034277A/en not_active Expired - Fee Related
-
2000
- 2000-02-29 CN CN00103696A patent/CN1278526A/en active Pending
- 2000-02-29 CN CN00103697A patent/CN1278527A/en active Pending
- 2000-02-29 CN CNB00103698XA patent/CN1137085C/en not_active Expired - Fee Related
- 2000-10-30 GR GR20000402398T patent/GR3034709T3/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101041629A (en) | New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it | |
| KR100739901B1 (en) | Process for the preparation of s,s-cis-2-benzhydryl-3-benzylaminoquinuclidine | |
| CN1155568C (en) | Method for producing 3-alkanoylindoles and 3-alkylindoles | |
| CN100343227C (en) | Process for resolution of tamsulosin | |
| CN1436176A (en) | 4-Alkoxy-cyclohexane-1-amino-carboxylate and its production method | |
| CN1278528A (en) | Process for preparation of 5,6-dihydroxyl-2-amino-1,2,3,4-tetrahydronaphthalene derivatives | |
| CN1910134A (en) | New process for the synthesis of substituted alpha-aminoidan derivatives | |
| CN1145613C (en) | Catechol hydrazone derivatives, preparation method thereof, and pharmaceutical composition containing the derivatives | |
| WO2014072998A1 (en) | An improved process for preparation of agomelatine | |
| CN1407981A (en) | Method for producing 5-(1piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination | |
| CN1564806A (en) | Preparation method of α-difluoromethylornithine (DFMO) | |
| CN1639111A (en) | Process for preparing 2-aminoindan derivatives | |
| AU2010294283B2 (en) | Process for preparing Cinacalcet | |
| JP4406482B2 (en) | Process for producing optically active 2-aminocyclohexanol derivative | |
| CN1832918A (en) | Process for producing optically active 1-alkyl-substituted 2,2,2-trifluoroethylamine | |
| NZ502786A (en) | Preparation of gabapentin analogues comprised of adding cyclohexanone to sodium hydride and finally heating the formed lactam in HCl and dioxan | |
| MXPA96005090A (en) | Process for the preparation of derivatives of 5,6-dihidroxi-2-amino-1,2,3,4-tetrahidronaftal | |
| CN1244543C (en) | Method for preparing 4-(alkyl)-3-alkoxy-aniline compounds | |
| CN1305460A (en) | Process for preparation of R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole | |
| JP2829306B2 (en) | 2-amino-7-hydroxytetralin ether derivative | |
| CN1898194A (en) | A New Method for the Synthesis of Alkenyl Amide Derivatives | |
| CN1310886C (en) | Optically active phenol derivatives and preparation methods thereof | |
| SK287537B6 (en) | Method of producing N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenylpropylamine in its racemic or optically active form | |
| HK1002360B (en) | A process for the preparation of 5, 6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives | |
| CA2178361A1 (en) | Ethylamido fluorenes and improved method of making same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |